Ventilators Market

研究執行與發布：MarketsandMarkets　·　發布日期 2026-08-10　·　294 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Invasive Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics)- Global Forecast to 2031

報告摘要

The ventilators market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026 at a CAGR of 4.4% during the forecast period. Increasing respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and aging populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology—safety, accuracy, and patient outcomes—prompt healthcare professionals to invest in newer respiratory support equipment. The increasing burden of respiratory illnesses is thus driving market growth. The high-end ICU ventilators segment accounts for the largest share of the global ventilators market. Premium ICU ventilators dominate the global ventilators market because they are crucial for treating life-threatening conditions in intensive care units. These advanced devices offer a wide range of ventilation modes, sophisticated monitoring systems, and enhanced safety features, all of which are essential for critically ill patients. As the global population ages and the incidence of complex respiratory diseases rises, healthcare facilities are increasingly investing in next-generation ICU solutions. Additionally, continuous innovations and stringent regulations from governing bodies support the adoption of these advanced devices, making them the preferred choice for life-critical situations where optimal patient outcomes are important. Combined mode ventilation has the largest market share in the ventilators market. Combined mode ventilators hold the largest market share in the ventilator segment because they offer the best features of both volume- and pressure-controlled ventilation. This allows clinicians to tailor respiratory support to meet the individual needs of each patient. These ventilators enable precise control over tidal volumes while ensuring that pressure remains within safe limits to prevent lung injury, making them a versatile solution suitable for a variety of clinical situations. Additionally, the advanced monitoring systems and automated adjustments of these devices enhance convenience and improve patient outcomes. As a result, combined mode ventilators are highly sought after in intensive care units where critically ill patients require adaptable and flexible ventilation options. Moreover, ongoing technological innovations, increased investments in healthcare facilities, and a rise in respiratory illnesses have all contributed to the growing demand for combined mode ventilators in the market. Europe holds the second-largest market share in the ventilators market. Europe is the world's second-largest ventilators market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with a high incidence of respiratory conditions and an aging population, ensures rising demand for invasive and non-invasive ventilators. Europe benefits from a dynamic community of leading producers and continuous innovation, resulting in the development of advanced technologies that enhance patient outcomes. Coupled with progressive healthcare initiatives and comprehensive insurance coverage, Europe stands out as a significant market for ventilators globally, securing its position as the second-largest market shareholder. A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below: • By Company Type: Tier 1–25%, Tier 2–40%, and Tier 3–35% • By Designation: C-level–20%, Director Level–38%, and Others–40% • By Region: North America–37%, Europe–28%, Asia Pacific–26%, Latin America- 6%, and Middle East and Africa– 1% and GCC Countries– 2% Prominent players in this market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), ResMed (US), Nihon Kohden Corporation (Japan), ZOLL Medical Corporation (US), Getinge AB (Sweden), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), Löwenstein Medical SE & Co. KG (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Skanray Technologies Ltd. (India), aXcent Medical GmbH (Germany), Metran Co., Ltd. (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Breas Medical AB (Sweden), Airon Corporation (US), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany), AgVa Healthcare (India), Biodesign Innovation Labs (India), NOCCARC Robotics Pvt. Ltd. (India), Umbulizer (India), Schiller Healthcare India Pvt. Ltd. (India), and AVI Healthcare (India). Research Coverage: The market study covers the ventilators market across various segments. It aims to estimate the market size and growth potential of this market across different segments by mobility, type, age group, interface, mode, care setting, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market. This report provides insights on:  Analysis of Market Dynamics: Drivers (Rise in respiratory diseases Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases), restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns), opportunities (Cost-efficiency of home care services, Growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)  Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.  Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and regions.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

授權報價

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

目錄 Table of Contents

1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED & REGIONS CONSIDERED 27 1.3.2 INCLUSIONS & EXCLUSIONS 28 1.4 YEARS CONSIDERED 28 1.5 CURRENCY USED 29 1.6 STAKEHOLDERS 29 1.7 LIMITATIONS 29 1.8 SUMMARY OF CHANGES 30 2 EXECUTIVE SUMMARY 31 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 31 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 33 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 34 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36 3 PREMIUM INSIGHTS 37 3.1 VENTILATORS MARKET OVERVIEW 37 3.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY AND COUNTRY (2025) 38 3.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39 3.4 VENTILATORS MARKET: REGIONAL MIX 39 3.5 VENTILATORS MARKET: DEVELOPED VS. EMERGING ECONOMIES 40 4 MARKET OVERVIEW 41 4.1 INTRODUCTION 41 4.2 MARKET DYNAMICS 41 4.2.1 DRIVERS 42 4.2.1.1 Rise in respiratory diseases 42 4.2.1.1.1 Increasing incidence of COPD and asthma 42 4.2.1.1.2 Growing tobacco consumption 42 4.2.1.2 Urbanization and rising pollution levels 43 4.2.1.3 Rising obesity due to sedentary lifestyles 43 4.2.1.4 Growing geriatric population worldwide 44 4.2.1.5 Increasing preference for home care settings 44 4.2.1.6 Rising number of preterm births 45 4.2.1.7 Outbreak of infectious respiratory diseases 45 4.2.2 RESTRAINTS 46 4.2.2.1 Shortage of skilled medical workers 46 4.2.2.2 Excessive purchase of ventilators during COVID-19 46 4.2.2.3 Reimbursement concerns 46 4.2.3 OPPORTUNITIES 47 4.2.3.1 Cost-efficiency of home care services 47 4.2.3.2 Growth opportunities in emerging economies 47 4.2.4 CHALLENGES 48 4.2.4.1 Low awareness and inadequate resources in emerging economies 48 4.2.4.2 Harmful effects of respiratory devices on neonates 48 4.2.4.3 Supply chain disruptions 48 4.2.4.4 Global demand fluctuations 49 4.3 UNMET NEEDS & WHITE SPACES 49 4.3.1 UNMET NEEDS IN VENTILATORS MARKET 49 4.3.2 WHITE SPACE OPPORTUNITIES 50 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 50 4.4.1 INTERCONNECTED MARKETS 50 4.4.2 CROSS-SECTOR OPPORTUNITIES 51 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 52 5 INDUSTRY TRENDS 53 5.1 PORTER’S FIVE FORCES ANALYSIS 53 5.1.1 THREAT OF NEW ENTRANTS 54 5.1.2 THREAT OF SUBSTITUTES 55 5.1.3 BARGAINING POWER OF SUPPLIERS 55 5.1.4 BARGAINING POWER OF BUYERS 55 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 55 5.2 MACROECONOMIC OUTLOOK 56 5.2.1 INTRODUCTION 56 5.2.2 GDP TRENDS & FORECAST 56 5.2.3 TRENDS IN GLOBAL VENTILATORS INDUSTRY 58 5.2.4 TRENDS IN GLOBAL HEALTHCARE & CRITICAL CARE INDUSTRY 58 5.3 SUPPLY CHAIN ANALYSIS 58 5.4 VALUE CHAIN ANALYSIS 60 5.5 ECOSYSTEM ANALYSIS 62 5.6 PRICING ANALYSIS 63 5.6.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025 63 5.6.2 AVERAGE SELLING PRICE TREND OF VENTILATORS, BY REGION, 2023–2025 63 5.7 TRADE ANALYSIS 64 5.7.1 IMPORT SCENARIO (HS CODE 9018) 65 5.7.2 EXPORT DATA (HS CODE 9018) 65 5.8 KEY CONFERENCES & EVENTS, 2026–2027 66 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 5.10 INVESTMENT & FUNDING SCENARIO 68 5.11 CASE STUDY ANALYSIS 68 5.11.1 CASE STUDY 1: SCALING AI-ENABLED CRITICAL CARE VENTILATION 68 5.11.2 CASE STUDY2: EXPANDING HOME RESPIRATORY CARE THROUGH CONNECTED VENTILATION 69 5.11.3 CASE STUDY 3: ENHANCING ICU RESPIRATORY CARE WITH INTEGRATED VENTILATION 69 5.12 IMPACT OF 2025 US TARIFFS ON VENTILATORS MARKET 70 5.12.1 INTRODUCTION 70 5.12.2 KEY TARIFF RATES 71 5.12.3 PRICE IMPACT ANALYSIS 72 5.12.4 IMPACT ON COUNTRIES/REGIONS 72 5.12.4.1 North America 72 5.12.4.2 Europe 72 5.12.4.3 Asia Pacific 73 5.12.5 END-USE INDUSTRY IMPACT 73 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 74 6.1 KEY EMERGING TECHNOLOGIES 74 6.1.1 INTELLIGENT & CLOSED-LOOP VENTILATION SYSTEMS 74 6.2 COMPLEMENTARY TECHNOLOGIES 74 6.2.1 REMOTE MONITORING SYSTEMS 74 6.3 TECHNOLOGY/PRODUCT ROADMAP 75 6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 75 6.3.2 1.16.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 75 6.3.3 1.16.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 76 6.4 PATENT ANALYSIS 76 6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 77 6.5 FUTURE APPLICATIONS 78 6.5.1 AI-ENABLED REMOTE VENTILATION MANAGEMENT & PREDICTIVE CARE 78 6.5.2 SMART RESPIRATORY CARE ECOSYSTEMS 79 6.5.3 ADVANCED VENTILATOR CONSUMABLES & LUNG-PROTECTIVE SOLUTIONS 79 6.6 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 80 6.6.1 TOP USE CASES & MARKET POTENTIAL 80 6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN VENTILATORS MARKET 80 6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81 6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN VENTILATORS MARKET 82 7 REGULATORY LANDSCAPE 83 7.1 REGIONAL REGULATIONS & COMPLIANCE 83 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 7.1.2 INDUSTRY STANDARDS 85 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 87 8.1 DECISION-MAKING PROCESS 87 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 87 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 87 8.2.2 BUYING CRITERIA 88 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 89 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 89 8.5 MARKET PROFITABILITY 90 8.5.1 REVENUE POTENTIAL 90 8.5.2 COST DYNAMICS 91 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 91 9 VENTILATORS MARKET, BY MOBILITY 92 9.1 INTRODUCTION 93 9.2 INTENSIVE CARE VENTILATORS 93 9.2.1 HIGH-END ICU VENTILATORS 96 9.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market 96 9.2.2 MID-END ICU VENTILATORS 98 9.2.2.1 Higher affordability and accessibility to drive market 98 9.2.3 BASIC ICU VENTILATORS 100 9.2.3.1 Growing use in ambulatory care centers to drive market 100 9.3 PORTABLE/TRANSPORTABLE VENTILATORS 101 9.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET 101 10 VENTILATORS MARKET, BY TYPE 104 10.1 INTRODUCTION 105 10.2 ADULT & PEDIATRIC VENTILATORS 105 10.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET 105 10.3 NEONATAL & INFANT VENTILATORS 106 10.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET 106 11 VENTILATORS MARKET, BY INTERFACE 108 11.1 INTRODUCTION 109 11.2 DUAL-CAPABILITY VENTILATION 109 11.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET GROWTH 109 11.3 NON-INVASIVE VENTILATION 110 11.3.1 RELIABILITY OF MECHANICAL DESIGNS TO SUPPORT MARKET GROWTH 110 11.4 INVASIVE VENTILATION 111 11.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 111 12 VENTILATORS MARKET, BY MODE 113 12.1 INTRODUCTION 114 12.2 COMBINED-MODE VENTILATORS 114 12.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET 114 12.3 VOLUME-MODE VENTILATORS 115 12.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET 115 12.4 PRESSURE-MODE VENTILATORS 116 12.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET 116 12.5 OTHER VENTILATOR MODES 118 13 VENTILATORS MARKET, BY CARE SETTING 120 13.1 INTRODUCTION 121 13.2 HOSPITALS & CLINICS 121 13.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET 121 13.3 AMBULATORY CARE CENTERS 122 13.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 122 13.4 EMERGENCY MEDICAL SERVICES 123 13.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET 123 13.5 HOME CARE SETTINGS 124 13.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET 124 14 VENTILATORS MARKET, BY REGION 126 14.1 INTRODUCTION 127 14.2 NORTH AMERICA 127 14.2.1 US 131 14.2.1.1 High prevalence of COPD to drive the market 131 14.2.2 CANADA 133 14.2.2.1 Increasing incidence of asthma to drive market growth 133 14.3 EUROPE 135 14.3.1 GERMANY 138 14.3.1.1 Rising healthcare spending to increase demand for high-end ventilators 138 14.3.2 FRANCE 140 14.3.2.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals 140 14.3.3 UK 143 14.3.3.1 Increasing healthcare expenditure to drive market growth 143 14.3.4 ITALY 145 14.3.4.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market 145 14.3.5 SPAIN 148 14.3.5.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth 148 14.3.6 NETHERLANDS 150 14.3.6.1 Rising prevalence of respiratory diseases to drive market 150 14.3.7 REST OF EUROPE 152 14.4 ASIA PACIFIC 154 14.4.1 JAPAN 158 14.4.1.1 Established healthcare system to increase adoption of respiratory care devices 158 14.4.2 CHINA 160 14.4.2.1 High prevalence of COPD and lung cancer to propel demand 160 14.4.3 INDIA 162 14.4.3.1 Rising focus of global players on Indian market to drive adoption of advanced ventilators 162 14.4.4 AUSTRALIA 165 14.4.4.1 High prevalence of chronic lung diseases to drive demand for ventilators 165 14.4.5 REST OF ASIA PACIFIC 167 14.5 LATIN AMERICA 169 14.5.1 BRAZIL 172 14.5.1.1 Healthcare infrastructure improvement to support market growth 172 14.5.2 MEXICO 174 14.5.2.1 Rising obesity rate to increase incidence of respiratory diseases 174 14.5.3 ARGENTINA 177 14.5.3.1 Incidence of severe acute respiratory infections to drive market 177 14.5.4 REST OF LATIN AMERICA 179 14.6 MIDDLE EAST & AFRICA 181 14.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET 181 14.7 GCC COUNTRIES 184 14.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH 184 15 COMPETITIVE LANDSCAPE 187 15.1 OVERVIEW 187 15.1.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET 188 15.2 REVENUE ANALYSIS, 2021–2025 189 15.3 MARKET SHARE ANALYSIS, 2025 189 15.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 191 15.4.1 STARS 191 15.4.2 EMERGING LEADERS 191 15.4.3 PERVASIVE PLAYERS 191 15.4.4 PARTICIPANTS 192 15.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 192 15.4.5.1 Company footprint 193 15.4.5.2 Company footprint 194 15.4.5.3 Mobility footprint 195 15.4.5.4 Type footprint 196 15.4.5.5 Interface footprint 197 15.4.5.6 Mode footprint 198 15.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 199 15.5.1 PROGRESSIVE COMPANIES 199 15.5.2 RESPONSIVE COMPANIES 199 15.5.3 DYNAMIC COMPANIES 199 15.5.4 STARTING BLOCKS 199 15.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 201 15.5.5.1 Detailed list of key startups/SMEs 201 15.5.5.2 Competitive benchmarking of key startups/SMEs 202 15.6 R&D EXPENDITURE 202 15.7 COMPANY VALUATION & FINANCIAL METRICS 203 15.7.1 FINANCIAL METRICS 203 15.7.2 COMPANY VALUATION 203 15.8 BRAND/PRODUCT COMPARISON 204 15.9 COMPETITIVE SCENARIO 204 15.9.1 PRODUCT LAUNCHES 205 15.9.2 DEALS 206 15.9.3 OTHER DEVELOPMENTS 208 16 COMPANY PROFILES 210 16.1 KEY PLAYERS 210 16.1.1 DRÄGERWERK AG & CO. KGAA 210 16.1.1.1 Business overview 210 16.1.1.2 Products offered 211 16.1.1.3 Recent developments 212 16.1.1.3.1 Product launches 212 16.1.1.3.2 Deals 212 16.1.1.3.3 Other developments 213 16.1.1.4 MnM view 213 16.1.1.4.1 Key strengths 213 16.1.1.4.2 Strategic choices 213 16.1.1.4.3 Weaknesses & competitive threats 214 16.1.2 GETINGE AB 215 16.1.2.1 Business overview 215 16.1.2.2 Products offered 216 16.1.2.3 Recent developments 217 16.1.2.3.1 Product launches 217 16.1.2.3.2 Deals 217 16.1.2.3.3 Other developments 217 16.1.2.4 MnM view 218 16.1.2.4.1 Key strengths 218 16.1.2.4.2 Strategic choices 218 16.1.2.4.3 Weaknesses & competitive threats 218 16.1.3 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 219 16.1.3.1 Business overview 219 16.1.3.2 Products offered 220 16.1.3.3 Recent developments 221 16.1.3.3.1 Product launches 221 16.1.3.3.2 Other developments 221 16.1.3.4 MnM view 222 16.1.3.4.1 Key strengths 222 16.1.3.4.2 Strategic choices 222 16.1.3.4.3 Weaknesses & competitive threats 222 16.1.4 ASAHI KASEI CORPORATION 223 16.1.4.1 Business overview 223 16.1.4.2 Products offered 224 16.1.4.3 Recent developments 225 16.1.4.3.1 Deals 225 16.1.5 RESMED INC. 226 16.1.5.1 Business overview 226 16.1.5.2 Products offered 227 16.1.5.3 Recent developments 228 16.1.5.3.1 Product launches 228 16.1.5.3.2 Deals 228 16.1.5.3.3 Other developments 228 16.1.5.4 MnM view 229 16.1.5.4.1 Key strengths 229 16.1.5.4.2 Strategic choices 229 16.1.5.4.3 Weaknesses & competitive threats 229 16.1.6 KONINKLIJKE PHILIPS N.V. 230 16.1.6.1 Business overview 230 16.1.6.2 Products offered 231 16.1.6.3 Recent developments 232 16.1.6.3.1 Other developments 232 16.1.6.4 MnM view 232 16.1.6.4.1 Key strengths 232 16.1.6.4.2 Strategic choices 232 16.1.6.4.3 Weaknesses & competitive threats 233 16.1.7 ICU MEDICAL INC. 234 16.1.7.1 Business overview 234 16.1.7.2 Products offered 235 16.1.7.3 Recent developments 236 16.1.7.3.1 Deals 236 16.1.7.4 MnM view 236 16.1.7.4.1 Key strengths 236 16.1.7.4.2 Strategic choices 236 16.1.7.4.3 Weaknesses & competitive threats 237 16.1.8 AIR LIQUIDE 238 16.1.8.1 Business overview 238 16.1.8.2 Products offered 239 16.1.8.3 MnM view 240 16.1.8.3.1 Key strengths 240 16.1.8.3.2 Strategic choices 240 16.1.8.3.3 Weaknesses & competitive threats 241 16.1.9 FLEXICARE (GROUP) LIMITED 242 16.1.9.1 Business overview 242 16.1.9.2 Products offered 243 16.1.9.3 Recent developments 243 16.1.9.3.1 Deals 243 16.1.10 NIHON KOHDEN CORPORATION 244 16.1.10.1 Business overview 244 16.1.10.2 Products offered 245 16.1.10.3 Recent developments 245 16.1.10.3.1 Product launches 245 16.1.10.4 MnM view 245 16.1.10.4.1 Key strengths 245 16.1.10.4.2 Strategic choices 246 16.1.10.4.3 Weaknesses & competitive threats 246 16.1.11 GE HEALTHCARE 247 16.1.11.1 Business overview 247 16.1.11.2 Products offered 248 16.1.11.3 MnM view 248 16.1.11.3.1 Key strengths 248 16.1.11.3.2 Strategic choices 249 16.1.11.3.3 Weaknesses & competitive threats 249 16.1.12 HAMILTON MEDICAL 250 16.1.12.1 Business overview 250 16.1.12.2 Products offered 250 16.1.12.3 Recent developments 250 16.1.12.3.1 Product upgrades 250 16.1.12.3.2 Deals 251 16.1.12.3.3 Other developments 251 16.1.12.4 MnM view 252 16.1.12.4.1 Key strengths 252 16.1.12.4.2 Strategic choices 252 16.1.12.4.3 Weaknesses & competitive threats 252 16.1.13 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH & CO. KG 253 16.1.13.1 Business overview 253 16.1.13.2 Products offered 253 16.1.13.3 MnM view 255 16.1.13.3.1 Key strengths 255 16.1.13.3.2 Strategic choices 255 16.1.13.3.3 Weaknesses & competitive threats 255 16.2 OTHER PLAYERS 256 16.2.1 SKANRAY TECHNOLOGIES, LTD. 256 16.2.2 METRAN CO., LTD. 257 16.2.3 MAGNAMED 257 16.2.4 LEISTUNG INGENIERÍA SRL 258 16.2.5 AIRON CORPORATION 258 16.2.6 TRITON ELECTRONIC SYSTEMS LTD. 259 16.2.7 BIO-MED DEVICES, INC. 259 16.2.8 HEYER MEDICAL AG 260 16.2.9 AGVA HEALTHCARE 260 16.2.10 SCHILLER AG 261 16.2.11 AVI HEALTHCARE LIMITED 262 16.2.12 MAGNAMEDIA B.V. 263 16.2.13 BREAS MEDICAL AB 264 16.2.14 BEIJING AEONMED CO., LTD 265 16.2.15 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD 266 16.2.16 REACT HEALTH 267 16.2.17 MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD 268 16.2.18 CHIRANA MEDICAL, A.S. 269 17 RESEARCH METHODOLOGY 270 17.1 RESEARCH DATA 270 17.1.1 SECONDARY RESEARCH 271 17.1.2 PRIMARY RESEARCH 272 17.2 MARKET SIZE ESTIMATION 276 17.3 MARKET BREAKDOWN & DATA TRIANGULATION 282 17.4 RESEARCH ASSUMPTIONS 283 17.5 RESEARCH LIMITATIONS 284 17.5.1 SCOPE-RELATED LIMITATIONS 284 17.5.2 METHODOLOGY-RELATED LIMITATIONS 284 17.6 RISK ASSESSMENT 284 18 APPENDIX 285 18.1 DISCUSSION GUIDE 285 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 290 18.3 CUSTOMIZATION OPTIONS 292 18.4 RELATED REPORTS 292 18.5 AUTHOR DETAILS 293

圖表清單 List of Tables & Figures

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 29 TABLE 2 DISORDERS AND DEATHS CAUSED BY SMOKING, 2024 42 TABLE 3 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 53 TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 56 TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025 (USD) 63 TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023–2025 (USD) 64 TABLE 7 IMPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 65 TABLE 8 EXPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 66 TABLE 9 VENTILATORS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027) 66 TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES “RECIPROCAL TARIFF, ADJUSTED" FOR THE TOP 20 TRADE PARTNERS 71 TABLE 11 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR VENTILATORS 71 TABLE 12 VENTILATORS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 80 TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 19 GLOBAL STANDARDS IN VENTILATORS MARKET 86 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 88 TABLE 21 KEY BUYING CRITERIA FOR VENTILATORS 89 TABLE 22 VENTILATORS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 89 TABLE 23 VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 93 TABLE 24 INTENSIVE CARE VENTILATORS: KEY PRODUCTS 93 TABLE 25 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 94 TABLE 26 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95 TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 95 TABLE 28 HIGH-END ICU VENTILATORS: KEY PRODUCTS 96 TABLE 29 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 30 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 97 TABLE 31 MID-END ICU VENTILATORS: KEY PRODUCTS 98 TABLE 32 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99 TABLE 33 MID-END ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 99 TABLE 34 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100 TABLE 35 BASIC ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 101 TABLE 36 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS 102 TABLE 37 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102 TABLE 38 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 103 TABLE 39 VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 105 TABLE 40 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS 105 TABLE 41 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106 TABLE 42 NEONATAL & INFANT VENTILATORS: KEY PRODUCTS 107 TABLE 43 NEONATAL & INFANT VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 44 VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 109 TABLE 45 DUAL-CAPABILITY VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 46 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 47 INVASIVE VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112 TABLE 48 VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 114 TABLE 49 COMBINED-MODE VENTILATORS: KEY PRODUCTS 114 TABLE 50 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 51 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 52 PRESSURE-MODE VENTILATORS: KEY PRODUCTS 117 TABLE 53 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 54 OTHER VENTILATOR MODES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 55 VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 121 TABLE 56 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 57 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 58 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 59 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 60 VENTILATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 127 TABLE 61 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 62 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 129 TABLE 63 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 129 TABLE 64 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 129 TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 130 TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 130 TABLE 67 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 130 TABLE 68 US: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 131 TABLE 69 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131 TABLE 70 US: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 71 US: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 132 TABLE 72 US: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 132 TABLE 73 US: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 133 TABLE 74 CANADA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 133 TABLE 75 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 76 CANADA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 77 CANADA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 134 TABLE 78 CANADA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 135 TABLE 79 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 135 TABLE 80 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 81 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 136 TABLE 82 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 83 EUROPE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137 TABLE 84 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 137 TABLE 85 EUROPE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 137 TABLE 86 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 138 TABLE 87 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 138 TABLE 88 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 89 GERMANY: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 90 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 139 TABLE 91 GERMANY: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 140 TABLE 92 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 140 TABLE 93 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 141 TABLE 94 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 141 TABLE 95 FRANCE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 141 TABLE 96 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 142 TABLE 97 FRANCE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 142 TABLE 98 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 142 TABLE 99 UK: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 143 TABLE 100 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144 TABLE 101 UK: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144 TABLE 102 UK: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 144 TABLE 103 UK: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 145 TABLE 104 UK: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 145 TABLE 105 ITALY: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 146 TABLE 106 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 107 ITALY: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 108 ITALY: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 147 TABLE 109 ITALY: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 147 TABLE 110 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 147 TABLE 111 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 148 TABLE 112 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 113 SPAIN: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 114 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 149 TABLE 115 SPAIN: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 149 TABLE 116 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 149 TABLE 117 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 150 TABLE 118 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 119 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 120 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 151 TABLE 121 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 151 TABLE 122 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 151 TABLE 123 REST OF EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 152 TABLE 124 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 125 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 153 TABLE 126 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 153 TABLE 127 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 153 TABLE 128 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 154 TABLE 129 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 130 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 156 TABLE 131 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 132 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 133 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 157 TABLE 134 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 157 TABLE 135 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 157 TABLE 136 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 158 TABLE 137 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 138 JAPAN: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 159 TABLE 139 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 159 TABLE 140 JAPAN: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 159 TABLE 141 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 160 TABLE 142 CHINA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 160 TABLE 143 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 144 CHINA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 145 CHINA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 161 TABLE 146 CHINA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION). 162 TABLE 147 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 162 TABLE 148 INDIA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 163 TABLE 149 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163 TABLE 150 INDIA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163 TABLE 151 INDIA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 164 TABLE 152 INDIA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 164 TABLE 153 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 164 TABLE 154 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 165 TABLE 155 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 156 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 157 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 166 TABLE 158 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 166 TABLE 159 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 167 TABLE 160 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 167 TABLE 161 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 162 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 163 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 168 TABLE 164 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 169 TABLE 165 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 169 TABLE 166 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 167 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 170 TABLE 168 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 169 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 170 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 171 TABLE 171 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 171 TABLE 172 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 172 TABLE 173 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 172 TABLE 174 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 175 BRAZIL: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 176 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 173 TABLE 177 BRAZIL: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 174 TABLE 178 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 174 TABLE 179 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 175 TABLE 180 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 175 TABLE 181 MEXICO: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 175 TABLE 182 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 176 TABLE 183 MEXICO: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 176 TABLE 184 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 176 TABLE 185 ARGENTINA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 177 TABLE 186 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 187 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 188 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 178 TABLE 189 ARGENTINA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 178 TABLE 190 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 179 TABLE 191 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 179 TABLE 192 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 180 TABLE 193 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 180 TABLE 194 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 180 TABLE 195 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 181 TABLE 196 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 181 TABLE 197 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 182 TABLE 198 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 199 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 200 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 183 TABLE 201 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 183 TABLE 202 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 183 TABLE 203 GCC COUNTRIES: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 184 TABLE 204 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 205 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 206 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 185 TABLE 207 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 186 TABLE 208 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 186 TABLE 209 VENTILATORS MARKET: DEGREE OF COMPETITION 190 TABLE 210 VENTILATORS MARKET: REGION FOOTPRINT 194 TABLE 211 VENTILATORS MARKET: MOBILITY FOOTPRINT 195 TABLE 212 VENTILATORS MARKET: TYPE FOOTPRINT 196 TABLE 213 VENTILATORS MARKET: INTERFACE FOOTPRINT 197 TABLE 214 VENTILATORS MARKET: MODE FOOTPRINT 198 TABLE 215 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 201 TABLE 216 VENTILATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 202 TABLE 217 VENTILATORS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 205 TABLE 218 VENTILATORS MARKET: DEALS, JANUARY 2021–JUNE 2026 206 TABLE 219 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 208 TABLE 220 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 210 TABLE 221 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 211 TABLE 222 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 212 TABLE 223 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JUNE 2026 212 TABLE 224 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 213 TABLE 225 GETINGE AB: COMPANY OVERVIEW 215 TABLE 226 GETINGE AB: PRODUCTS OFFERED 216 TABLE 227 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 217 TABLE 228 GETINGE AB: DEALS, JANUARY 2021–JUNE 2026 217 TABLE 229 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 217 TABLE 230 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 219 TABLE 231 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 220 TABLE 232 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 221 TABLE 233 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 221 TABLE 234 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 223 TABLE 235 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 224 TABLE 236 ASAHI KASEI CORPORATION: DEALS, JANUARY 2021–JUNE 2026 225 TABLE 237 RESMED INC.: COMPANY OVERVIEW 226 TABLE 238 RESMED INC.: PRODUCTS OFFERED 227 TABLE 239 RESMED INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 228 TABLE 240 RESMED INC.: DEALS, JANUARY 2021–JUNE 2026 228 TABLE 241 RESMED INC.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 228 TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 230 TABLE 243 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 231 TABLE 244 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 232 TABLE 245 ICU MEDICAL INC.: COMPANY OVERVIEW 234 TABLE 246 ICU MEDICAL INC.: PRODUCTS OFFERED 235 TABLE 247 ICU MEDICAL INC.: DEALS, JANUARY 2021–JUNE 2026 236 TABLE 248 AIR LIQUIDE: COMPANY OVERVIEW 238 TABLE 249 AIR LIQUIDE: PRODUCTS OFFERED 239 TABLE 250 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 242 TABLE 251 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 243 TABLE 252 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021–JUNE 2026 243 TABLE 253 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 244 TABLE 254 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 245 TABLE 255 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 245 TABLE 256 GE HEALTHCARE: COMPANY OVERVIEW 247 TABLE 257 GE HEALTHCARE: PRODUCTS OFFERED 248 TABLE 258 HAMILTON MEDICAL: COMPANY OVERVIEW 250 TABLE 259 HAMILTON MEDICAL: PRODUCTS OFFERED 250 TABLE 260 HAMILTON MEDICAL: PRODUCT UPGRADES, JANUARY 2021–JUNE 2026 250 TABLE 261 HAMILTON MEDICAL: DEALS, JANUARY 2021–JUNE 2026 251 TABLE 262 HAMILTON MEDICAL: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 251 TABLE 263 RISK ASSESSMENT 284 FIGURE 1 VENTILATORS MARKET SEGMENTATION & REGIONS COVERED 27 FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 31 FIGURE 3 VENTILATORS MARKET, 2024–2031 32 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENTILATORS MARKET 33 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF VENTILATORS MARKET 34 FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN VENTILATORS MARKET, 2026 35 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 36 FIGURE 8 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET 37 FIGURE 9 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2025 38 FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 39 FIGURE 11 NORTH AMERICA WILL DOMINATE MARKET TILL 2031 39 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD 40 FIGURE 13 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41 FIGURE 14 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024 43 FIGURE 15 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015 VS. 2020 VS. 2023 44 FIGURE 16 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 54 FIGURE 17 VENTILATORS MARKET: SUPPLY CHAIN ANALYSIS 60 FIGURE 18 VENTILATORS MARKET: VALUE CHAIN ANALYSIS 61 FIGURE 19 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 62 FIGURE 20 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023–2025 (USD) 64 FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 FIGURE 22 VENTILATORS MARKET: INVESTMENT & FUNDING SCENARIO 68 FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2016─JULY 2026) 77 FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VENTILATORS (JANUARY 2016− JULY 2026) 78 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 88 FIGURE 26 KEY BUYING CRITERIA FOR VENTILATORS 88 FIGURE 27 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 128 FIGURE 28 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 155 FIGURE 29 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 188 FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET, 2021–2025 189 FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET, 2025 190 FIGURE 32 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 192 FIGURE 33 VENTILATORS MARKET: COMPANY FOOTPRINT 193 FIGURE 34 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 200 FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2024 VS. 2025) 202 FIGURE 36 EV/EBITDA OF KEY VENDORS 203 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 203 FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS 204 FIGURE 39 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025) 211 FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2025) 216 FIGURE 41 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025) 220 FIGURE 42 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2025) 224 FIGURE 43 RESMED INC.: COMPANY SNAPSHOT (2025) 227 FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 231 FIGURE 45 SMITHS GROUP PLC: COMPANY SNAPSHOT (2025) 235 FIGURE 46 AIR LIQUIDE: COMPANY SNAPSHOT (2025) 239 FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2025) 244 FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 248 FIGURE 49 RESEARCH DESIGN 270 FIGURE 50 KEY DATA FROM SECONDARY SOURCES 272 FIGURE 51 PRIMARY SOURCES 272 FIGURE 52 KEY DATA FROM PRIMARY SOURCES 273 FIGURE 53 KEY INDUSTRY INSIGHTS 274 FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE & DEMAND-SIDE PARTICIPANTS 274 FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 275 FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION 275 FIGURE 57 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 276 FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: DRÄGERWERK AG & CO. KGAA (GERMANY) (2025) 277 FIGURE 59 SUPPLY-SIDE MARKET SIZE ESTIMATION 278 FIGURE 60 DEMAND-SIDE MARKET SIZE ESTIMATION 279 FIGURE 61 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2026–2031) 280 FIGURE 62 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 281 FIGURE 63 TOP-DOWN APPROACH 282 FIGURE 64 DATA TRIANGULATION METHODOLOGY 283

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們